Literature DB >> 15210959

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.

Nan Wang1, Debin Lan, Wengen Chen, Fumihiko Matsuura, Alan R Tall.   

Abstract

The mechanisms responsible for the inverse relationship between plasma high-density lipoprotein (HDL) levels and atherosclerotic cardiovascular disease are poorly understood. The ATP-binding cassette transporter A1 (ABCA1) mediates efflux of cellular cholesterol to lipid-poor apolipoproteins but not to HDL particles that constitute the bulk of plasma HDL. We show that two ABC transporters of unknown function, ABCG1 and ABCG4, mediate isotopic and net mass efflux of cellular cholesterol to HDL. In transfected 293 cells, ABCG1 and ABCG4 stimulate cholesterol efflux to both smaller (HDL-3) and larger (HDL-2) subclasses but not to lipid-poor apoA-I. Treatment of macrophages with an liver X receptor activator results in up-regulation of ABCG1 and increases cholesterol efflux to HDL. RNA interference reduced the expression of ABCG1 in liver X receptor-activated macrophages and caused a parallel decrease in cholesterol efflux to HDL. These studies indicate that ABCG1 and ABCG4 promote cholesterol efflux from cells to HDL. ABCG1 is highly expressed in macrophages and probably mediates cholesterol efflux from macrophage foam cells to the major HDL fractions, providing a mechanism to explain the relationship between HDL levels and atherosclerosis risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210959      PMCID: PMC470750          DOI: 10.1073/pnas.0403506101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems.

Authors:  M Krieger
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.

Authors:  K E Berge; H Tian; G A Graf; L Yu; N V Grishin; J Schultz; P Kwiterovich; B Shan; R Barnes; H H Hobbs
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

3.  Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice.

Authors:  E Orsó; C Broccardo; W E Kaminski; A Böttcher; G Liebisch; W Drobnik; A Götz; O Chambenoit; W Diederich; T Langmann; T Spruss; M F Luciani; G Rothe; K J Lackner; G Chimini; G Schmitz
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

4.  Characterization of four lipoprotein classes in human cerebrospinal fluid.

Authors:  S Koch; N Donarski; K Goetze; M Kreckel; H J Stuerenburg; C Buhmann; U Beisiegel
Journal:  J Lipid Res       Date:  2001-07       Impact factor: 5.922

5.  ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein.

Authors:  N Wang; D L Silver; C Thiele; A R Tall
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

Review 6.  Role of ABCG1 and other ABCG family members in lipid metabolism.

Authors:  G Schmitz; T Langmann; S Heimerl
Journal:  J Lipid Res       Date:  2001-10       Impact factor: 5.922

7.  Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein.

Authors:  M A Kennedy; A Venkateswaran; P T Tarr; I Xenarios; J Kudoh; N Shimizu; P A Edwards
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

8.  ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages.

Authors:  J F Oram; R M Lawn; M R Garvin; D P Wade
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

9.  Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1.

Authors:  N Wang; D L Silver; P Costet; A R Tall
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

10.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

View more
  276 in total

1.  An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells.

Authors:  Jeffrey M Sturek; J David Castle; Anthony P Trace; Laura C Page; Anna M Castle; Carmella Evans-Molina; John S Parks; Raghavendra G Mirmira; Catherine C Hedrick
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.

Authors:  Urbain Tchoua; Corina Rosales; Daming Tang; Baiba K Gillard; Ashley Vaughan; Hu Yu Lin; Harry S Courtney; Henry J Pownall
Journal:  Lipids       Date:  2010-10-24       Impact factor: 1.880

Review 3.  Moving out: from sterol transport to drug resistance - the ABCG subfamily of efflux pumps.

Authors:  Karobi Moitra; Latoya Silverton; Katy Limpert; Kate Im; Michael Dean
Journal:  Drug Metabol Drug Interact       Date:  2011-09-27

Review 4.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

Review 5.  ABCG transporters: structure, substrate specificities and physiological roles : a brief overview.

Authors:  Saroj Velamakanni; Shen L Wei; Tavan Janvilisri; Hendrik W van Veen
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

6.  Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.

Authors:  Laurent Yvan-Charvet; Mollie Ranalletta; Nan Wang; Seongah Han; Naoki Terasaka; Rong Li; Carrie Welch; Alan R Tall
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Inhibition of miR-486 and miR-92a decreases liver and plasma cholesterol levels by modulating lipid-related genes in hyperlipidemic hamsters.

Authors:  Loredan S Niculescu; Natalia Simionescu; Elena V Fuior; Camelia S Stancu; Mihaela G Carnuta; Madalina D Dulceanu; Mina Raileanu; Emanuel Dragan; Anca V Sima
Journal:  Mol Biol Rep       Date:  2018-05-03       Impact factor: 2.316

8.  PPARs in atherosclerosis: the clot thickens.

Authors:  Antonio Castrillo; Peter Tontonoz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

9.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.

Authors:  Andrew C Li; Christoph J Binder; Alejandra Gutierrez; Kathleen K Brown; Christine R Plotkin; Jennifer W Pattison; Annabel F Valledor; Roger A Davis; Timothy M Willson; Joseph L Witztum; Wulf Palinski; Christopher K Glass
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

10.  Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL.

Authors:  Yong Yang; Yan-Fu Wang; Xiao-Fang Yang; Zhao-Hui Wang; Yi-Tian Lian; Ying Yang; Xiao-Wei Li; Xiang Gao; Jian Chen; Yan-Wen Shu; Long-Xian Cheng; Yu-Hua Liao; Kun Liu
Journal:  J Lipid Res       Date:  2012-10-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.